Biofeedback for POTS: What It Is, How It Helps & Its Limitations
If you’ve tried multiple treatments to manage your POTS symptoms and are still struggling with daily life, you may be wondering whether biofeedback could help.
Published peer-reviewed research shows that Cognitive FX treatment leads to meaningful symptom reduction in post-concussion symptoms for 77% of study participants. Cognitive FX is the only PCS clinic with third-party validated treatment outcomes.
READ FULL STUDY
If you have postural orthostatic tachycardia syndrome, you already know what a flare feels like. Heart racing the moment you stand. The room tilting. A fatigue that is out of proportion to anything you actually did. What you may not know is exactly why it happens — or why some days are far worse than others.
POTS flares are not random. They follow a predictable logic rooted in how your autonomic nervous system (ANS) works and what pushes it past its tolerance threshold. Understanding that logic is the first step toward fewer bad days.
Understanding Your POTS
Tap any trigger to see exactly what's happening in your body — and what the evidence says about managing it.
All 10 Triggers — Tap to Expand
What's happening
When your body heats up, it redirects blood to the skin surface to cool down. In POTS, this compounds blood already pooling in your legs — a double draw on circulating volume the system cannot cover. Hot showers combine heat vasodilation with prolonged standing at once.
What helps
What's happening
Any illness causing fever, vomiting, diarrhea, or reduced intake compresses the circulating blood volume POTS already keeps too low. Immune activation releases cytokines that further disrupt autonomic signaling. For Long COVID patients, even a mild reinfection can restimulate the neuroinflammatory processes that caused POTS in the first place.
What helps
What's happening
POTS patients typically have below-normal circulating blood volume. Dehydration compresses this further. Low sodium reduces osmotic pressure, shifting fluid out of blood vessels into surrounding tissue — reducing intravascular volume even when total fluid intake looks adequate.
What helps
What's happening
Large meals divert blood to the GI tract within 30–60 minutes of eating — postprandial pooling is common in POTS. Alcohol causes peripheral vasodilation and acts as a diuretic. For patients with MCAS overlap, high-histamine foods trigger mast cell degranulation, releasing vasodilatory mediators that directly worsen blood pooling.
What helps
What's happening
Sleep is the primary window for autonomic nervous system recalibration. Disrupted sleep sustains sympathetic tone, raises cortisol, and prevents parasympathetic recovery. Morning symptoms are typically worst because overnight horizontal sleep followed by rapid standing is the day's most abrupt orthostatic challenge.
What helps
What's happening
Exercise diverts blood to muscles, raises core temperature, and demands cardiac output from a system already struggling. In the short term this can cause palpitations, presyncope, or a multi-hour crash. In the long term, structured recumbent exercise is one of the most powerful interventions for POTS — done at the right pace.
What helps
What's happening
When estrogen and progesterone are high (mid-luteal phase), they activate the renin-angiotensin-aldosterone system, retaining salt and water that partially compensates for POTS-related volume deficit. When both hormones drop before menstruation, that protective buffer disappears — and a pro-inflammatory prostaglandin cascade follows.
What helps
What's happening
Psychological stress directly activates the sympathetic nervous system. In POTS, where the parasympathetic counterbalance is already impaired, the stress response runs harder and longer. Fear of symptoms creates a reinforcing loop: palpitations trigger anxiety about palpitations. This is not the cause of POTS — but it absolutely amplifies and prolongs flares.
What helps
What's happening
Vasodilators, diuretics, tricyclic antidepressants, and SNRIs can all worsen orthostatic tolerance. In POTS-MCAS patients, beta-blockers carry a risk of mast cell activation. Caffeine is highly individual — its vasoconstriction can help some patients, while its sympathomimetic effect worsens others.
What helps
What's happening
Drops in barometric pressure cause peripheral vasodilation and reduce atmospheric compression that partially supports venous return. High humidity impairs sweat evaporation, raising internal temperature and driving further cutaneous vasodilation. Most POTS patients have worse summers and better falls.
What helps
Standard care manages the outputs.
We address the control system behind them.
Cognitive FX's POTS program targets autonomic retraining — teaching your nervous system to regulate itself, not just compensating around broken regulation.
See If Our Program Is Right for YouThis article covers the ten most common POTS flare triggers, the neurological mechanism behind each one, and what the evidence says about managing them — including why standard treatments help some patients but leave many others still struggling.
Before you can understand what triggers a flare, you need a working picture of what is already wrong.
POTS is not a heart problem. The heart rate spike is a symptom of a deeper failure — the autonomic nervous system's inability to properly regulate blood flow when your body changes position. When you stand up, gravity pulls roughly 500 to 750 milliliters of blood toward your legs and abdomen. In a healthy person, the ANS compensates automatically: blood vessels constrict, heart rate nudges upward slightly, and blood reaches the brain without a problem. In POTS, that compensation fails. Blood pools in the lower body, the heart races to compensate, and the brain does not get enough blood.
The reason the compensation fails is neurological. Specific brain regions — including the left anterior insula, the paraventricular nucleus of the hypothalamus, and brainstem structures like the nucleus tractus solitarius — are responsible for orchestrating the cardiovascular response to standing. Neuroimaging studies show measurable differences in these areas in POTS patients. When those control centers are not working properly, the system defaults to sympathetic overdrive: a persistent fight-or-flight state that cannot be easily dialed back.
This is the baseline state in POTS. The sympathetic nervous system is overactive. The parasympathetic branch — responsible for the "rest and digest" counterbalance — is underactive. The system is already operating near its limit.
A flare happens when something tips the balance further. Any additional physiological demand — heat, dehydration, a large meal, a stressful event, a hormonal shift — draws on compensatory reserves that are already depleted. The result is a symptomatic crisis that can last hours to days.
Not all POTS is the same, and your subtype determines which triggers are most dangerous for you.
Hyperadrenergic POTS involves elevated standing norepinephrine levels (above 600 pg/mL). These patients have the most exaggerated sympathetic responses. Emotional stress, stimulants, and histamine-releasing events are particularly dangerous, and blood pressure often rises rather than falls when standing.
Neuropathic POTS involves partial autonomic nerve damage that impairs peripheral vasoconstriction. Heat, prolonged standing, and dehydration hit hardest, because the blood vessels simply cannot tighten fast enough to compensate. Salt and fluid loading is especially important for this subgroup.
Long COVID-related POTS combines classical ANS dysfunction with ongoing neuroinflammation, possible small fiber neuropathy, and autoantibody production. Illness reactivation is the most dangerous trigger for relapse, and post-exertional malaise is more severe. These patients typically need slower, more conservative exercise progression than classic POTS.
POTS with hypermobile EDS (hEDS) adds connective tissue laxity to the picture. Stretchier blood vessel walls make pooling worse, even during minor orthostatic challenges. These patients often need higher sodium targets and may have difficulty tolerating compression garments.
POTS with Mast Cell Activation Syndrome (MCAS) is the most complex subgroup. Heat, high-histamine foods, stress, and certain medications can trigger mast cell degranulation, producing histamine and other inflammatory mediators that cause vasodilation and worsen blood pooling. The POTS-MCAS-hEDS triad is increasingly recognized as a distinct clinical pattern.
Yes — heat is one of the most universally reported POTS flare triggers, and the mechanism is well-established.
When the body gets hot, it redirects blood flow toward the skin surface to dissipate heat through convection and sweating. This is a sympathetically driven process. In a healthy person, this redistribution is manageable. In POTS, it creates a compounding problem: blood is simultaneously pooling in the legs because of impaired orthostatic compensation and being diverted to the skin for thermoregulation. The combined draw on circulating volume overwhelms an already-failing system.
Impaired baroreceptor signaling worsens this further. In POTS, the baroreceptors — the pressure sensors in the blood vessels that trigger compensatory responses — do not signal quickly or accurately enough to prevent the resulting drop in central blood volume and brain perfusion.
Hot showers are a particularly common trigger because they combine heat vasodilation with prolonged upright standing. A lukewarm shower with a shower chair is typically better tolerated. For MCAS patients, heat also directly activates mast cells, triggering degranulation of histamine and prostaglandins that cause additional vasodilation.
What helps: Pre-cooling before anticipated heat exposure (cooling vest, cold towel to the back of the neck, cold beverages), lukewarm rather than hot showers, and limiting time in high-humidity environments. During an acute heat-related flare, cold water immersion of hands and forearms can produce rapid vasoconstriction and partial symptom relief.
Exercise is both the most common short-term trigger and the most important long-term therapy for POTS. Understanding why requires separating the two time scales.
In the short term, exercise diverts blood to active muscles, raises core temperature, and places cardiovascular demands on a system that is already struggling to maintain adequate perfusion. In patients with hyperadrenergic POTS, exertion can push heart rate and norepinephrine to levels that cause palpitations, presyncope, or a post-exertional crash lasting hours.
In the long term, structured exercise increases blood volume, improves venous tone in the legs, and gradually retrains the autonomic system to better tolerate orthostatic stress. This is why the exercise paradox in POTS is so frustrating: the thing that helps most is also the thing most likely to cause a flare if done incorrectly.
What helps: Start with recumbent exercise only (rowing, swimming, recumbent cycling, gentle reclined strength training). Progress extremely slowly, using heart rate response and symptom load rather than a fixed schedule. Many POTS specialists recommend keeping heart rate below 110 bpm during activity early in rehabilitation. Hydrate aggressively before and after exercise. Pre-exercise salt loading is often useful.
Yes, and this is one of the most predictable patterns. Any illness that causes fever, vomiting, diarrhea, or reduced oral intake will reduce circulating blood volume — the resource that is already critically limited in POTS. Systemic infection also activates cytokine release and immune pathways that further impair ANS regulation.
For patients with Long COVID-related POTS, illness reactivation is particularly consequential. Reinfection with SARS-CoV-2 or other respiratory viruses can restimulate the same neuroinflammatory and autoimmune processes that caused POTS in the first place, producing significant relapse.
Illness-related flares often persist well past the acute infection. This is not unusual — the inflammatory load from even a mild virus can take two to three weeks to fully resolve, and autonomic symptoms may remain elevated throughout.
What helps: Establish a sick-day protocol with your provider in advance. Aggressive oral rehydration (electrolyte solutions rather than plain water) is the most important step. Temporarily increase sodium intake. Reduce activity to what is genuinely tolerable. Track heart rate as an objective guide to severity rather than relying on perceived exertion alone.
This is one of the most under-discussed POTS flare mechanisms, and the evidence is clear.
POTS is a strongly female-predominant condition, with research reporting up to 94% female predominance. Women with POTS consistently report symptom worsening that follows a predictable hormonal pattern: flares concentrate in the premenstrual and early follicular phases, when both estrogen and progesterone are falling or at their lowest.
The mechanism involves the renin-angiotensin-aldosterone system (RAAS). When estrogen and progesterone are high (mid-luteal phase), they activate the RAAS, promoting salt and water retention that increases circulating blood volume. This partially compensates for the orthostatic deficit. When both hormones drop at the end of the cycle, that compensatory volume is lost. Research has confirmed that plasma renin activity and aldosterone are measurably lower during the early follicular phase in POTS women, corresponding with higher rates of presyncope during standing tests.
The progesterone drop also triggers a pro-inflammatory cascade: decreased progesterone (an anti-inflammatory hormone) stimulates prostaglandin release, which increases inflammatory markers. For POTS patients already prone to inflammation-mediated symptom worsening, this creates a double hit.
What helps: Tracking the menstrual cycle alongside POTS symptoms is worthwhile for most female POTS patients. IV saline is particularly beneficial around menstruation, when it is accessible. Some patients benefit from hormonal contraceptive regimens that reduce cycle frequency. Salt and fluid loading in the premenstrual window can partially offset the RAAS decline.
Consistently, reliably, and sometimes dramatically. POTS patients typically already have below-normal circulating blood volume. Any further reduction from dehydration compresses this further and makes orthostatic compensation even more difficult.
Low sodium compounds the problem in a different way: it reduces osmotic pressure in the bloodstream, causing fluid to shift out of blood vessels and into surrounding tissues. The net effect is reduced intravascular volume even when total body fluid intake looks adequate.
The relationship is also bidirectional. Sympathetic overdrive in POTS itself drives increased sweating and urinary losses, meaning patients lose fluid faster than average. Some patients with POTS also have inappropriately suppressed aldosterone, which reduces the kidney's ability to retain sodium normally.
What helps: Target 2 to 3 liters of fluid daily (more in heat or during exercise). Most POTS specialists recommend 3,000 to 10,000 mg of sodium per day depending on subtype and blood pressure. Salt tablets with meals are practical. Electrolyte-rich drinks provide faster volume expansion than plain water.
Yes, and the mechanism is direct. Psychological stress activates the sympathetic nervous system and triggers release of epinephrine and norepinephrine. In a healthy person, the parasympathetic system moderates this response. In POTS patients, the parasympathetic counterbalance is already impaired, so the stress response runs longer and harder.
This creates a feedback loop that complicates treatment: POTS symptoms are frightening, and fear of symptoms activates the same sympathetic pathways that worsen those symptoms. Palpitations trigger anxiety about palpitations. Dizziness creates hypervigilance. The anxiety is not the cause of POTS — POTS is a genuine neurological condition — but the psychological response to symptoms can absolutely amplify and prolong flares.
Chronic stress matters as much as acute stress. Sustained cortisol elevation desensitizes baroreceptors over time and reduces parasympathetic tone, which keeps the system in a state of heightened reactivity.
What helps: Diaphragmatic (slow, belly) breathing is one of the most effective immediate interventions for stress-related POTS flares. It directly activates the parasympathetic nervous system via vagal stimulation. Heart rate variability (HRV) biofeedback can teach patients to shift their autonomic state more reliably. Cognitive behavioral approaches help reduce symptom-driven anxiety without dismissing the underlying physical dysfunction.
For many patients, yes. There are three distinct mechanisms.
Large meals and postprandial hypotension: When you eat a large meal, the body diverts blood to the gastrointestinal tract to support digestion. This redistribution can drop central blood volume enough to trigger orthostatic symptoms within 30 to 60 minutes of eating. This is called postprandial hypotension and it is common in POTS.
Alcohol: Alcohol causes peripheral vasodilation, routing blood toward the skin. It also has a significant diuretic effect, increasing urinary fluid losses. The combination reliably worsens POTS in almost all patients. There is no safe POTS-friendly alcohol quantity for most patients.
High-histamine foods and MCAS: For patients with concurrent MCAS, foods that are high in histamine or that trigger mast cell degranulation can cause a cascade of vasodilatory and pro-inflammatory effects that directly worsen POTS symptoms. Common high-histamine foods include aged cheeses, fermented foods, cured meats, wine and beer, spinach, tomatoes, and leftover cooked protein (bacteria in stored food produce histamine). Research has confirmed that in hyperadrenergic POTS patients with mast cell activation, histamine stimulates norepinephrine release, worsening the sympathetic overdrive that defines this subtype.
What helps: Smaller, more frequent meals (five to six per day) rather than three large ones. Staying hydrated during meals. Avoiding alcohol. For suspected MCAS overlap, a four to six-week low-histamine dietary trial is worth attempting, with guidance from a provider familiar with both conditions. For a broader look at lifestyle-based approaches, see our guide to natural remedies for POTS.
Yes, and this is a clinically important point because patients with POTS are often prescribed medications for other conditions that can inadvertently worsen their autonomic function.
Medication classes most likely to cause problems include:
Vasodilators and antihypertensives: Calcium channel blockers, nitrates, and alpha-blockers reduce peripheral vascular resistance, worsening blood pooling.
Diuretics: Reduce circulating volume in patients who often already have too little.
Tricyclic antidepressants: Known to worsen orthostatic intolerance through alpha-adrenergic blockade and antihistamine effects.
Sympathomimetics and stimulants: Amphetamines and SNRIs can push an already overactive sympathetic system further, particularly in hyperadrenergic POTS.
Beta-blockers and MCAS: An important nuance — beta-blockers have the potential to activate mast cells and should be used with extra caution in patients with POTS-MCAS overlap.
Caffeine is individualized. The vasoconstrictive effect is helpful for some patients. For others, the increase in heart rate and anxiety worsens symptoms. Trial and careful self-monitoring is the best approach.
What helps: Medication review by a provider knowledgeable about POTS is essential. Any new prescription from a non-POTS specialist should be evaluated for autonomic effects before starting.
Sleep is the primary window during which the autonomic nervous system resets. Disrupted or insufficient sleep sustains sympathetic tone, raises cortisol, and blunts parasympathetic recovery. POTS symptoms are consistently worse the morning after poor sleep.
Sleep disruption is both a symptom and a trigger — POTS-related tachycardia and discomfort make quality sleep difficult, and poor sleep then worsens the next day's POTS, creating a reinforcing cycle.
Morning symptoms are typically worst because lying down for hours followed by rapid upright positioning represents the most abrupt orthostatic challenge of the day. Overnight fluid redistribution means patients often wake with temporarily increased plasma volume, which then rapidly shifts when they stand.
What helps: Elevating the head of the bed by 6 to 8 inches is one of the most evidence-supported interventions for POTS-related morning symptoms. It reduces overnight fluid redistribution to the legs and partially simulates orthostatic conditioning during sleep. Consistent sleep timing and pre-sleep hydration also matter. Many patients benefit from a slow, deliberate standing protocol in the morning: sitting upright for several minutes before standing, and hydrating before any vertical activity.
Weather-related flares are widely reported by patients but less studied than other triggers. The most well-supported mechanisms involve heat and humidity (described above) and barometric pressure.
Drops in barometric pressure are associated with vasodilation and reduced atmospheric compression of peripheral blood vessels. For POTS patients, this translates to less external support for venous return, worsening the orthostatic pooling problem. High humidity compounds this by impairing sweat evaporation, which means the body cannot shed heat efficiently — internal temperature rises, driving further cutaneous vasodilation.
Seasonal patterns are common in POTS, with summer typically the worst period for most patients. Geographic relocation to cooler, lower-humidity environments genuinely helps some patients and is worth discussing with a provider.
What helps: Air conditioning, cooling vests, and avoiding prolonged outdoor activity during extreme heat or humidity. Tracking barometric pressure changes (several weather apps report this) alongside symptom diaries can help patients anticipate and prepare for high-risk weather windows.
This is the core issue behind why so many POTS patients plateau with standard care.
Every trigger discussed above ultimately works through the same mechanism: it pushes an already-dysregulated autonomic nervous system past its compensatory threshold. The question standard treatments rarely ask is why the system is so poorly calibrated in the first place.
The brain regions responsible for autonomic control — the insular cortex, hypothalamus, brainstem nuclei — show measurable structural and functional differences in POTS patients on advanced neuroimaging. These are the actual control centers for heart rate, blood pressure, vascular tone, and the baroreceptor reflexes that protect against orthostatic stress. When they are not working correctly, the cardiovascular outputs are going to be abnormal no matter how much salt you eat or how many compression garments you wear. Our overview of post-concussion autonomic dysfunction covers these brain mechanisms in more detail for patients whose POTS began after a head injury.
Standard POTS treatments target the outputs. They increase blood volume, slow the heart rate, or constrict blood vessels. These interventions are useful and often necessary. But they do not address the control centers that are generating the dysfunction.
There is no FDA-approved medication for POTS. Every drug used is prescribed off-label, based on relatively small trials, without standardized protocols. The treatment landscape reflects a condition that medicine has only recently taken seriously.
Beyond the regulatory gap, the core problem is that standard care targets the wrong level of the problem. Fludrocortisone increases blood volume. Midodrine constricts blood vessels. Beta-blockers slow the heart rate. Ivabradine (currently showing the best real-world response rates at around 78%) reduces heart rate through a different pathway. These are all peripheral interventions addressing peripheral consequences of central dysfunction. We look at this gap in more depth in our article on whether there is a cure for POTS.
A systematic review published in Frontiers in Neurology found no positive study supporting fludrocortisone for POTS, and symptomatic improvement in only 51% of patients using pyridostigmine. These are the most commonly prescribed medications for the condition.
The heterogeneity of POTS compounds this. Hyperadrenergic, neuropathic, hypovolemic, and autoimmune POTS all share a diagnostic label but have meaningfully different underlying mechanisms. A treatment approach calibrated for one subtype may be neutral or counterproductive for another.
Finally, the standard cardiology framework for POTS misses the neurological root cause. When the brain's autonomic control centers are dysfunctional, managing heart rate and blood pressure around that dysfunction is symptom management, not treatment.
For patients whose symptoms are not adequately controlled by standard management, the question worth asking is whether the autonomic nervous system itself can be retrained.
The answer, based on the neuroplasticity research and clinical experience, is yes — but it requires a different approach than symptom-focused care.
At Cognitive FX, we approach POTS as a neurological problem. The clinical evidence and our own imaging data consistently point to brain-level dysregulation as the driver of autonomic dysfunction. This is true whether POTS developed after a concussion, a viral illness, a period of deconditioning, or without obvious trigger.
Our POTS treatment program is built on the same neurological rehabilitation principles we developed treating post-concussion patients — many of whom presented with significant autonomic dysfunction. As those patients recovered through intensive neurological therapy, we consistently observed improvements in autonomic regulation: reduced resting tachycardia, better orthostatic tolerance, less post-exertional crash. Over time, those observations were formalized into a dedicated, four-day intensive POTS program. If you are evaluating your options, our guide to choosing the right POTS clinic outlines what to look for in any provider.
The core mechanism is interval-based autonomic retraining. POTS patients are typically stuck in sympathetic overdrive. Our approach uses carefully structured cycles of exertion followed by guided parasympathetic recovery — CO₂ therapy, diaphragmatic breathing, vestibular calibration, and sensory inputs — to teach the nervous system to transition more smoothly between its two states. Repeating these transitions in a controlled clinical environment creates the neuroplastic change that produces lasting improvement, rather than just short-term symptom relief.
For patients where appropriate, functional neuroimaging (our proprietary fNCI scan) identifies which specific brain regions are contributing to the dysregulation. This allows treatment to be targeted to the actual pattern of dysfunction rather than applied generically.
Treatment in our post-concussion patients achieves meaningful symptom improvement in 77% of participants, with outcomes validated by independent researchers. Our POTS program draws on the same clinical infrastructure and principles.
Our program is most appropriate for patients who:
We do not diagnose POTS — a tilt table test or standing test with documented heart rate criteria is required before coming to us. We also do not position our program as a replacement for ongoing medication management with your primary provider. Our focus is addressing what standard care cannot reach: the central nervous system dysfunction driving the condition.
If you have lived with POTS long enough to know that managing the symptoms is not the same as getting better, a neurological approach may be the next step worth taking.
Schedule a consultation with our team
POTS flares follow a logic. Heat, exertion, illness, hormonal shifts, dehydration, stress, food, medications, sleep disruption, and weather changes all worsen POTS through a common pathway: they push a dysregulated autonomic nervous system past its compensatory threshold. Understanding which triggers are most relevant to your subtype makes management more precise and less reactive.
The ten triggers covered in this article give you a working framework. But the deeper point is this: flare frequency and severity are not fixed. With the right approach — one that addresses the autonomic nervous system rather than working around it — most patients can do better than they currently are.
Alina Fong, Ph.D. is a clinical neuropsychologist and the Clinical Director and Co-Founder of Cognitive FX. She earned her Ph.D. in Clinical Neuropsychology with an emphasis in Neuroimaging from Brigham Young University, where she received the American Psychological Association Division 40 Graduate Student Research Award for her neuroimaging research. Dr. Fong has over 17 years of clinical experience treating traumatic brain injury, beginning with her work at the VA Salt Lake City Healthcare System and Utah Valley Regional Medical Center, where she directed the neurotrauma rehabilitation and sports concussion clinics. She developed the EPIC Treatment protocol and has personally overseen treatment for nearly 8,000 brain injury patients, including professional athletes from the NFL, NHL, and Olympics. She serves as Vice President of the Brain Injury Alliance of Utah, sits on the board of the United States Brain Injury Alliance, and advises PINK Concussions. Dr. Fong has authored peer-reviewed research on functional MRI and concussion treatment and has presented at over 60 medical conferences, including the Federal Interagency Conference on TBI and the American Medical Society for Sports Medicine.
If you’ve tried multiple treatments to manage your POTS symptoms and are still struggling with daily life, you may be wondering whether biofeedback could help.
If you've ever stood up and felt your heart start racing, felt lightheaded out of nowhere, or experienced brain fog so thick you couldn't finish a sentence, you might be dealing with something called...
COVID-19 can affect the autonomic and central nervous systems. It can affect organ systems directly through infection or indirectly via dysfunction in the nervous system. That means a host of...
If you’re living with POTS, you’ve probably wondered: Is this ever going to get better?
When you get a concussion, you may worry about when it’s safe to sleep. You might even have a friend or a family member wake you up every few hours. And while that is sometimes necessary (if you have...
Published peer-reviewed research shows that Cognitive FX treatment leads to meaningful symptom reduction in post-concussion symptoms for 77% of study participants. Cognitive FX is the only PCS clinic with third-party validated treatment outcomes.
READ FULL STUDY